Timor Baasov
Affiliations: | Technion - Israel Institute of Technology, Haifa, Haifa District, Israel |
Google:
"Timor Baasov"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Micha Fridman | grad student | 2005 | Technion |
| Moran Shalev–Benami | grad student | 2008-2013 | Technion INstitute of Technology (Cell Biology Tree) |
| Jeyakumar Kandasamy | post-doc | 2008-2011 | Technion |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shalev M, Rozenberg H, Smolkin B, et al. (2015) Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics. Nucleic Acids Research. 43: 8601-13 |
| Baasov T, Fridman M, Werz DB. (2015) Carbohydrates: Special issue in honor of the 2014 wolf prize laureate in chemistry, professor Chi-Huey Wong Israel Journal of Chemistry. 55: 253 |
| Baasov T, Fridman M. (2014) Foreword-The 17th European Carbohydrate Symposium-EuroCarb17. Carbohydrate Research. 389: 1 |
| Gunn G, Dai Y, Du M, et al. (2014) Long-term nonsense suppression therapy moderates MPS I-H disease progression. Molecular Genetics and Metabolism. 111: 374-81 |
| Gunn GG, Dai Y, Du M, et al. (2014) Long-term nonsense suppression therapy with NB84 moderates MPS IH disease progression Molecular Genetics and Metabolism. 111: S50 |
| Shalev M, Kondo J, Kopelyanskiy D, et al. (2013) Identification of the molecular attributes required for aminoglycoside activity against Leishmania. Proceedings of the National Academy of Sciences of the United States of America. 110: 13333-8 |
| Keeling KM, Wang D, Dai Y, et al. (2013) Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. Plos One. 8: e60478 |
| Shalev M, Kandasamy J, Skalka N, et al. (2013) Development of generic immunoassay for the detection of a series of aminoglycosides with 6'-OH group for the treatment of genetic diseases in biological samples. Journal of Pharmaceutical and Biomedical Analysis. 75: 33-40 |
| Kandasamy J, Atia-Glikin D, Shulman E, et al. (2012) Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: A strategy for treatment of genetic diseases caused by nonsense mutations Journal of Medicinal Chemistry. 55: 10630-10643 |
| Wang D, Belakhov V, Kandasamy J, et al. (2012) The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Molecular Genetics and Metabolism. 105: 116-25 |